. . . . . . . . . "lantus is indicated to improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus important limitations of use lantus is not recommended for the treatment of diabetic ketoacidosis intravenous short acting insulin is the preferred treatment for this condition lantus is a long acting human insulin analog indicated to improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus 1 important limitations of use not recommended for treating diabetic ketoacidosis use intravenous short acting insulin instead" . . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "ikM5xsSpiNQ3vPwQpDbs6vkOi3RMLOCCQ9G/ZBB+w1tPcs41tCpYEV9h2Mh5luTmlaJEEyzJAnc6GFRW1lOcIY2zjDmF1QQtDzVHscqsgISIaTV6J8qzdPlsr1DCh9cYiGZUwn9+KgbfSsqZX1beD1/oed8Lr4gGoQrBMNHNaFE=" . . "2021-06-12T13:35:30.936+02:00"^^ . . . . .